《大行報告》花旗:港交所(00388.HK)有信心將有更多中概股來港掛牌 重申長線看好
花旗發表報告表示近日舉行亞太區投資者會議,並與港交所(00388.HK)管理層進行會面,該行引述港交所重申未來將有更多中概股來本港掛牌上市,而該行近期亦留意到在美國上市的中概股京東及網易計劃來本港掛牌。
該行指,港交所正進行企業版「同權不同權」諮詢,相信科技股未來可提升在指數中的權重佔比,料每隻中概股來港上市,或可提升港股日均成交額約1%,估計港股未來日均成交額可望提升。
就恆指服務公司早前公布未來允計「同權不同權」或第二上市股份獲納入恆指及國指成份股,花旗相信亦對港交所影響正面。該行指,早於今年3月已上調對港交所評級至「買入」,因看好其結構性增長前景,如未來迎來更多中概股上市、南向資金流入第二上市股份、A股期貨等,目前重申長線看好港交所,維持「買入」評級及目標價278元。(wl/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.